Pramipexole
Active pharmaceutical substance formulated in Jan Aushadhi generic products for CNS, Nerve & Mental Health treatment.
🧴 Clinical Application
Take orally with water, with or without food; taking with food reduces nausea. Titrate dose gradually at weekly intervals as prescribed. Do not discontinue suddenly.
⚠️ Side Effects
Common: Nausea, dizziness, somnolence, insomnia, constipation, asthenia, peripheral edema, orthostatic hypotension. Rare/Severe: Sudden onset of sleep during daily activities (including driving), impulse control disorders (compulsive gambling, binge eating, hypersexuality), hallucinations, and postural deformities (camptocormia).
🛡️ Safety Warnings
Warn patients about the risk of falling asleep without warning during activities requiring alertness (driving). Monitor for impulse control disorders; dosage reduction or discontinuation is curative. Dose adjustment required in renal impairment.
Jan Aushadhi Products containing Pramipexole
Found 3 generic formulation(s) containing this active ingredient.
Pramipexole Dihydrochloride Tablets 0.25mg
Pramipexole is a non-ergoline dopamine agonist with high relative intrinsic activity and selectivity for dopamine D2, D3, and D4 receptor subtypes, with preferential affinity for D3 receptors in the mesolimbic system. It stimulates striatal dopamine receptors directly, bypassing degenerating nigrostriatal neurons. Indicated for the treatment of signs and symptoms of idiopathic Parkinson's disease (as monotherapy in early disease or adjunct to levodopa) and moderate-to-severe primary Restless Legs Syndrome (RLS).
Pramipexole 0.75mg Tablets
Pramipexole is a non-ergoline dopamine agonist with high relative intrinsic activity and selectivity for dopamine D2, D3, and D4 receptor subtypes, with preferential affinity for D3 receptors in the mesolimbic system. It stimulates striatal dopamine receptors directly, bypassing degenerating nigrostriatal neurons. Indicated for the treatment of signs and symptoms of idiopathic Parkinson's disease (as monotherapy in early disease or adjunct to levodopa) and moderate-to-severe primary Restless Legs Syndrome (RLS).
Pramipexole 1.5mg Tablets
Pramipexole is a non-ergoline dopamine agonist with high relative intrinsic activity and selectivity for dopamine D2, D3, and D4 receptor subtypes, with preferential affinity for D3 receptors in the mesolimbic system. It stimulates striatal dopamine receptors directly, bypassing degenerating nigrostriatal neurons. Indicated for the treatment of signs and symptoms of idiopathic Parkinson's disease (as monotherapy in early disease or adjunct to levodopa) and moderate-to-severe primary Restless Legs Syndrome (RLS).
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Pramipexole.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Pramipexole Dihydrochloride Tablets 0.25mg | 10's | ₹45.94 | PRAMIPEX, PRAMIROL, PREXOL, PIMAPEXOLE, PRAMIRISE | ₹94.20 | 51% Save |
| Pramipexole 0.75mg Tablets | 10's | ₹15.00 | PRAMIPEX, PEXOS | ₹146.25 | 90% Save |
| Pramipexole 1.5mg Tablets | 10's | ₹24.38 | PRAMIPEX, PEXOS | ₹249.75 | 90% Save |
Frequently Asked Questions (FAQ)
Get answers to common queries about Pramipexole generics.